Pulse Biosciences (PLSE) Receivables - Net (2021 - 2026)

Pulse Biosciences has reported Receivables - Net for 4 years, with the latest figure at $122000.0 in Q2 2026.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $122000.0 in Q2 2026; TTM through Jun 2026 was $122000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $274000.0, changed N/A from the prior year.
• Receivables - Net was $122000.0 for Q2 2026 at Pulse Biosciences, down from $274000.0 in the prior quarter.
• The five-year high for Receivables - Net was $274000.0 in Q4 2025, with the low at $5000.0 in Q3 2022.
• Average Receivables - Net over 3 years is $74166.7, with a median of $18000.0 recorded in 2022.
• The largest YoY upside for Receivables - Net was 93.06% in 2022 against a maximum downside of 93.06% in 2022.
• Over 3 years, Receivables - Net stood at $5000.0 in 2022, then surged by 5380.0% to $274000.0 in 2025, then plunged by 55.47% to $122000.0 in 2026.
• The last three Receivables - Net figures came in at $122000.0 (Q2 2026), $274000.0 (Q4 2025), and $15000.0 (Q3 2025), per Business Quant data.